GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 25, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7KRA | 7KRA | Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs | |
7KQI | 7KQI | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
7KQH | 7KQH | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
7KQG | 7KQG | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
7KQB | 7KQB | SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I | |
7KPB | 7KPB | Human TNF-alpha TNFR1 complex bound to conformationally selective antibody | |
7KO8 | 7KO8 | Cryo-EM structure of the mature and infective Mayaro virus | |
7KNA | 7KNA | Localized reconstruction of the H1 A/Michigan/45/2015 ectodomain displayed at the surface of I53_dn5 nanoparticle | |
7KNA | 7KNA | Localized reconstruction of the H1 A/Michigan/45/2015 ectodomain displayed at the surface of I53_dn5 nanoparticle | |
7KN7 | 7KN7 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3 | |
7KN6 | 7KN6 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3 | |
7KN5 | 7KN5 | Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U | |
7KN4 | 7KN4 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab | |
7KN3 | 7KN3 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab | |
7KML | 7KML | cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound | |
7KMK | 7KMK | cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound | |
7KMI | 7KMI | LY-CoV481 neutralizing antibody against SARS-CoV-2 | |
7KMH | 7KMH | LY-CoV488 neutralizing antibody against SARS-CoV-2 | |
7KMD | 7KMD | Crystal structure of a HIV-1 clade C isolate Du172.17 HR1.R4.664 Env trimer in complex with human Fabs PGT124 and 35O22 | |
7KM5 | 7KM5 | Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 | |
7KLH | 7KLH | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
7KLG | 7KLG | SARS-CoV-2 RBD in complex with Fab 15033 | |
7KLC | 7KLC | Crystal structure of M4H2K1 Fab bound to HIV-1 BG505 gp120 core and to 17b Fab | |
7KL9 | 7KL9 | Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) | |
7KKR | 7KKR | Fluoride channel Fluc-Ec2 wild-type with bromide | |
7KKL | 7KKL | SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 | |
7KKK | 7KKK | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | |
7KKB | 7KKB | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
7KKA | 7KKA | Fluoride channel Fluc-Ec2 mutant S81A with bromide | |
7KK9 | 7KK9 | Fluoride channel Fluc-Ec2 mutant S81A/T82A with bromide | |
7KK8 | 7KK8 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
7KJH | 7KJH | Plasmodium falciparum protein Pf12p bound to nanobody B9 | |
7KI6 | 7KI6 | Structure of the HeV F glycoprotein in complex with the 1F5 neutralizing antibody | |
7KI4 | 7KI4 | Structure of the NiV F glycoprotein in complex with the 12B2 neutralizing antibody | |
7KHF | 7KHF | CryoEM structure of LILRB1 D3D4 domain-inserted antibody MDB1 Fab in complex with Plasmodium RIFIN (PF3D7_1373400) V2 domain | |
7KFY | 7KFY | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab) | |
7KFX | 7KFX | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab) | |
7KFW | 7KFW | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab) | |
7KFV | 7KFV | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab) | |
7KFH | 7KFH | Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-437 | |
7KFE | 7KFE | Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329 | |
7KFB | 7KFB | Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442 | |
7KF9 | 7KF9 | Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-296 and EBOV-515 | |
7KEX | 7KEX | Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-293 | |
7KEW | 7KEW | Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-43 | |
7KEJ | 7KEJ | BDBV-289 bound to EBOV GPdMuc Makona | |
7KEI | 7KEI | DQA1*01:02/DQB1*06:02 in complex with a hemagglutinin peptide from the H1N1 pandemic flu virus. | |
7KDU | 7KDU | Ricin bound to VHH antibody V5E4 | |
7KDM | 7KDM | Ricin bound to VHH antibody V5G6 | |
7KDE | 7KDE | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024